-+ 0.00%
-+ 0.00%
-+ 0.00%

Lantern Pharma rises; FDA clears IND No. 179145 for STAR-001 Phase 1 pediatric CNS cancer trial

Reuters·03/27/2026 11:29:15

Please log in to view news